/Companies

Zenflow

YC W15

San Francisco, US · Founded 2014 · Delaware corporation · 18 employees · 23 known investors

Find your way into Zenflow

Sign up to see every warm intro you have to Zenflow

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Zenflow team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.

Also known as Torix Medical, Inc.

HealthtechMedical DevicesUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (W15)

Zenflow was founded in 2014 by Shreya Mehta and Nick Damiano.

SMShreya Mehta
Shreya MehtaCTO
NDNick Damiano
Nick DamianoCEO2014–2023Nick Damiano founded three medical device companies, including two with significant FDA regulatory approvals and hospital deployments. He is a Stanford graduate and Y Combinator alumnus focused on healthcare technology development.
JB
John BeckExecutiveJohn Beck is a finance and accounting executive with 29 years of experience across hardware, software, semiconductors, medical devices, and manufacturing. He holds a CPA credential and has worked with organizations ranging from public companies to early-stage startups, with expertise in cash management, strategic planning, and corporate governance.

Board

BK
Bryan KimBoard director
RWRobert Weisskoff
Robert WeisskoffBoard directorSenior Partner at F-Prime Capital Partners
BR
Blayne RoederBoard director
SS
Susan StimsonBoard director
RC
Radu CautisBoard directorGeneral Partner at Medical Technology Venture Partners
AC
Andrew CleelandBoard director

Investors · 23

Astialisted by AstiaSilicon Valley

How we know: Y Combinator's founder network · Not right? Tell us

Agrolimen Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

Golden SeedsreportedFlushing · $250K – $2M

How we know: the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

GSD CapitalreportedLondon

How we know: Y Combinator's founder network · Not right? Tell us

IDrive Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

InvusreportedNew York

How we know: Y Combinator's founder network · Not right? Tell us

LLLPreportedGrand Forks

How we know: Y Combinator's founder network · Not right? Tell us

SP Investment Fundreported

How we know: Y Combinator's founder network · Not right? Tell us

StartXreportedStanford · $10K – $1M

How we know: Y Combinator's founder network · Not right? Tell us

Sv Tech Ventures, Inc.reportedPalo Alto

How we know: Y Combinator's founder network · Not right? Tell us

Tandem CapitalreportedMenlo Park · $500K

How we know: Y Combinator's founder network · Not right? Tell us

TechVision FondsreportedAachen · $540K – $2.2M

How we know: Y Combinator's founder network · Not right? Tell us

TH CapitalreportedKuala Lumpur

How we know: Y Combinator's founder network · Not right? Tell us

Varsity VCreportedParis

How we know: Y Combinator's founder network · Not right? Tell us

Venture Investment AssociatesreportedPeapack

How we know: Y Combinator's founder network · Not right? Tell us

Also in the syndicate · 1

Invus Opportunitieslead

Reported raises · per SEC filings

Form D private placements

$75.3M disclosed across 3 rounds · 2017–2024

▶$19.4MraisedNov 2024 · 36 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Susan StimsonDirector
  • Bryan KimDirector
  • John BeckExecutive Officer
  • Radu CautisDirector
  • Andrew CleelandDirector
  • Robert WeisskoffDirector
  • Blayne RoederDirector
  • Shreya MehtaExecutive Officer, Director
Offering amount
$25.2M
Amount sold
$19.4M
Minimum investment
$1
First sale
Nov 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$24.4MraisedMay 2021 · 43 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Shreya MehtaExecutive Officer, Director
  • Bryan KimDirector
  • Nick DamianoExecutive Officer, Director
  • Radu CautisDirector
  • Robert WeisskoffDirector
  • Andrew CleelandDirector
Offering amount
$24.4M
Amount sold
$24.4M
Minimum investment
$1
First sale
Apr 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$31.5MraisedDec 2017 · 86 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Shreya MehtaExecutive Officer, Director
  • Bryan KimDirector
  • Nicholas DamianoExecutive Officer, Director
  • Robert WeisskoffDirector
  • Radu CautisDirector
Offering amount
$32.2M
Amount sold
$31.5M
Minimum investment
$1
First sale
Sep 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 10

Spire HealthSpire Health provides continuous respiratory monitoring devices used by pulmonologists and patients to track lung disease. The company's sensors enable remote tracking of chronic respiratory conditions across the United States.
MedflowMedFlow is a clinical operations platform designed for healthcare providers to automate and optimize clinical workflows, integrating with Athenahealth EHR systems. It offers templated preventative care workflows and consulting support to help provider organizations scale quality care delivery.
Shift LabsShift Labs develops DripAssist, an FDA-cleared infusion rate monitor that enables safe delivery of gravity IV medications in home and out-of-hospital settings. The platform remotely tracks medication infusion rates and provides data analytics for healthcare providers administering home infusion therapy.
NeuroFlowNeuroFlow builds behavioral health integration platforms that identify population behavioral health risk, engage individuals with acuity-specific resources, and give care teams data to make decisions. It serves healthcare organizations and health systems aiming to improve outcomes and lower total cost of care.
X-ZellX-ZELL develops cryoimmunostaining platforms and multiplex panels for cytology laboratories, enabling extraction of multiple biomarkers from single tissue specimens while preserving samples for further testing. The company serves pathologists, oncologists, and diagnostic partners primarily in Southeast Asia with CE-marked, ISO 13485-certified reagents and workflow solutions.
BodyportBodyport develops an FDA-cleared cardiac scale that non-invasively measures hemodynamic biomarkers through a patient's feet to detect early signs of worsening heart failure in a home setting. The company's platform pairs this hardware with a proprietary algorithm called the Congestion Index and a software system that integrates with electronic health records to enable remote patient monitoring and clinical decision support for heart failure management.
ClearflowClearFlow develops PleuraFlow Active Clearance Technology, a device that maintains chest drain patency after cardiac surgery to reduce Retained Blood Syndrome complications, along with products for sternal fixation and reconstruction following sternotomy. The products are used in ICU and surgical settings for post-cardiac-surgery patient care.
KlarismoKlarismo provides cloud-based software that converts full-body MRI scans into interactive 3D virtual models of the body, with automated analysis of body composition including muscle and fat tissue measurements. The platform uses machine learning to analyze large volumes of scans simultaneously without manual processing.
Cardio FlowCardioFlow develops medical devices for interventional cardiology, specifically addressing critical limb-threatening ischemia through non-surgical therapies. The company serves interventional cardiologists and cardiovascular specialists.
HeartFlowHeartflow provides an AI-based analysis that converts a coronary CTA scan into a personalized 3D model of the heart, assessing anatomy and physiology to help diagnose and manage coronary artery disease (CAD). Its platform, Heartflow One, is used by cardiologists and clinicians to guide diagnosis and treatment decisions for patients.

Companies working in the same space as Zenflow.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2019$1.3M
National Institutes of Health (NIH)National Institutes of HealthPhase II2017$1.3M
National Science FoundationPhase I2015$150K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Legal entities · 2

corporate structure
Torix Medical, Inc.
Zenflow, Inc.

In the news

Frequently asked questions

What does Zenflow do?
Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.
Who founded Zenflow?
Zenflow was founded by Shreya Mehta, Nick Damiano in 2014.
Who are Zenflow's investors?
Zenflow's investors include Astia, CloudStone Capital, Dorm Room, F-Prime Capital, ShangBay Capital LLC, Y Combinator, Agrolimen Ventures, Golden Seeds and 14 more.
How much funding has Zenflow raised?
Zenflow has disclosed $75.3M raised across 3 rounds.
Where is Zenflow headquartered?
Zenflow is headquartered in San Francisco, US.